{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:43:57Z","timestamp":1789983837339,"version":"4.0.1"},"publisher-location":"Chichester, UK","reference-count":76,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002798.pub2","type":"reference-entry","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T13:01:47Z","timestamp":1082725307000},"source":"Crossref","is-referenced-by-count":33,"title":["Benzodiazepine receptor antagonists for hepatic encephalopathy"],"prefix":"10.1002","author":[{"given":"Bodil","family":"Als-Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,19]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB1|cit1","first-page":"88","article-title":"Effects of flumazenil on subclinical hepatic encephalopathy (SHE) [EASL abstract]","volume":"18 Suppl","author":"Amodio","year":"1993","journal-title":"Jounal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD002798.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2281.1997.05656.x","article-title":"The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study","volume":"17","author":"Amodio","year":"1997","journal-title":"Clinical physiology"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/hep.510280212","article-title":"Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study","volume":"28","author":"Barbaro","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00063110-199806000-00004","article-title":"Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study","volume":"5","author":"Barbaro","year":"1998","journal-title":"European Journal of Emergency Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB5|cit5","first-page":"325","article-title":"Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study","volume":"7","author":"Cadranel","year":"1995","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(91)91390-3","article-title":"Immediate improvement of hepatic encephalopathy (HE) in cirrhotic patients by flumazenil. Results of a double-blind cross-over study [EASL abstract]","volume":"13 Suppl","author":"Cadranel","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB7|cit7","unstructured":"El Younsi M Cadranel JF Pidoux B Zylberberg P Valla D The immediate effect on the clinical grade and electroencephalogram of cirrhotic patients with hepatic encephalopathy Gastroenterologie Clinique et Biologique 1991 A216"},{"key":"10.1002\/14651858.CD002798.pub2-BIB8|cit8","first-page":"118","article-title":"The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study","volume":"133","author":"Dursun","year":"2003","journal-title":"Swiss Medical Weekly"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02246294","article-title":"Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy","volume":"119","author":"Gooday","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0013-4694(95)00200-6","article-title":"Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial","volume":"98","author":"Groeneweg","year":"1996","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/gut.39.2.319","article-title":"Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study","volume":"39","author":"Gyr","year":"1996","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB12|cit12","first-page":"A942","article-title":"Treatment of portosystemic encephalopathy with the benzodiazepine-receptor antagonist flumazenil (a randomized, double-blind, placebo-controlled, multicenter study)","volume":"106 Suppl","author":"Meier","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB13|cit13","first-page":"R172","article-title":"The clinical and electroencephalographic effects of flumazenil in acute hepatic encephalopathy","volume":"10 Suppl","author":"Hermant","year":"1991","journal-title":"Annales Francaises d'Anesthesie et de Reanimation"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02246197","article-title":"Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients","volume":"120","author":"Kapczinski","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB15|cit15","doi-asserted-by":"crossref","unstructured":"Klotz U Walker S Flumazenil and hepatic encephalopathy [letter] Lancet 1989 155 6 89096153","DOI":"10.1016\/S0140-6736(89)91165-3"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1590-8658(00)80027-4","article-title":"Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: A double blind randomized placebo controlled study","volume":"32","author":"Lacetti","year":"2000","journal-title":"Digestive and Liver Disease"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB17|cit17","first-page":"32","article-title":"Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial [see comments]","volume":"19","author":"Pomier Layrargues","year":"1994","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0016-5085(94)90252-6","article-title":"Flumazenil for hepatic coma: the elusive wake-up call?","volume":"107","author":"Sterling","year":"1994","journal-title":"Gastroenterology"},{"issue":"6-7","key":"10.1002\/14651858.CD002798.pub2-BIB19|cit19","first-page":"572","article-title":"Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study","volume":"19","author":"Rijt","year":"1995","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD002798.pub2-BIB20|cit20","unstructured":"van der Rijt CCD Schalm SW Meulstee J Stijnen T Flumazenil therapy for hepatic encephalopathy: a double-blind cross-over study [abstract] Hepatology 1989 590"},{"key":"10.1002\/14651858.CD002798.pub2-BIB21|cit21","first-page":"355","article-title":"Flumazenil in the treatment of cirrhotic patients with hepatic encephalopathy: A randomized doubled-blind clinical trial","volume":"18","author":"Zhu","year":"1998","journal-title":"Chinese Journal of Digestion"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0016-5085(89)90647-1","article-title":"Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans","volume":"97","author":"Bansky","year":"1989","journal-title":"Gastroenterology"},{"issue":"8609","key":"10.1002\/14651858.CD002798.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(88)90146-8","article-title":"Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials [letter]","volume":"2","author":"Burke","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.1840110323","article-title":"Benzodiazepine receptors and hepatic encephalopathy","volume":"11","author":"Butterworth","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002798.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00023210-199708020-00001","article-title":"Benzodiazepine-like substances and hepatic encephalopathy. Implications for treatment","volume":"8","author":"Cossar","year":"1997","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01701483","article-title":"Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure","volume":"21","author":"Devictor","year":"1995","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0016-5085(89)90787-7","article-title":"Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil","volume":"96","author":"Ferenci","year":"1989","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD002798.pub2-BIB28|cit28","first-page":"322","article-title":"[Benzodiazepine antagonists in the treatment of heptic encephalopathy]","volume":"19","author":"Ferenci","year":"1989","journal-title":"Leber, Magen, Darm"},{"key":"10.1002\/14651858.CD002798.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(99)00817-4","article-title":"The effect of flumazenil on visual event-related potentials of clinically non-encephalopathic patients with cirrhosis","volume":"276","author":"Giger-Mateeva","year":"1999","journal-title":"Neuroscience Letters"},{"issue":"1-2","key":"10.1002\/14651858.CD002798.pub2-BIB30|cit30","first-page":"32","article-title":"Effects of flumazenil (benzodiazepine antagonist) in hepatic coma","volume":"18","author":"Golubovic","year":"1999","journal-title":"Archives of Gastroenterohepatology"},{"issue":"8625","key":"10.1002\/14651858.CD002798.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(88)90587-9","article-title":"Improvement of hepatic encephalopathy treated with flumazenil","volume":"2","author":"Grimm","year":"1988","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002798.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01731153","article-title":"Flumazenil in the treatment of portal systemic encephalopathy-an overview","volume":"17","author":"Gyr","year":"1991","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB33|cit33","first-page":"46","article-title":"Flumazenil in the treatment of hepatic encephalopathy","volume":"27","author":"Howard","year":"1993","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD002798.pub2-BIB34|cit34","first-page":"56","article-title":"A prospective, controlled study on flumazenil therapy for portal-systemic shunt encephalopathy","volume":"7","author":"Jia","year":"1999","journal-title":"Chinese Journal of Hepatology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1011662411913","article-title":"Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil","volume":"1-2","author":"Jones","year":"2001","journal-title":"Metabolic Bain Disease"},{"issue":"6","key":"10.1002\/14651858.CD002798.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jnnp.60.6.676","article-title":"Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors","volume":"60","author":"Kapczinski","year":"1996","journal-title":"Journal of Nurology, Nurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0750-7658(05)80259-X","article-title":"Treatment of hepatic encephalopathy with flumazenil (letter)","volume":"9","author":"Marsepoil","year":"1990","journal-title":"Annales Francaises d'Anesthesie et de Reanimation."},{"key":"10.1002\/14651858.CD002798.pub2-BIB38|cit38","first-page":"139","article-title":"Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study","volume":"2","author":"Meier","year":"1988","journal-title":"European Journal of Anaesthesiology. Supplement"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB39|cit39","first-page":"210","article-title":"Evoked potentials and the effect of flumazenil in patients with liver cirrhosis","volume":"74","author":"Ozyilkan","year":"1997","journal-title":"East African Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD002798.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0987-7053(89)80003-6","article-title":"Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy","volume":"19","author":"Pidoux","year":"1989","journal-title":"Neurophysiologie Clinique"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0750-7658(05)80253-9","article-title":"Treatment of acute hepatic encephalopathy with flumazenil","volume":"9","author":"Viel","year":"1990","journal-title":"Annales Francaises d'Anesthesie et de Reanimation"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB42|cit42","first-page":"323","article-title":"GABA, benzodiazepines and hepatic encephalopathy","volume":"7","author":"Wilkinson","year":"1995","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD002798.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.42.6.861","article-title":"Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum","volume":"42","author":"Avallone","year":"1998","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB45|cit45","first-page":"27","article-title":"The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands","volume":"43","author":"Basile","year":"1991","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD002798.pub2-BIB46|cit46","first-page":"1341","article-title":"Fulminant and subfulminant liver failure","volume-title":"Clinical Hepatology","volume":"2","author":"Bernuau","year":"1999"},{"key":"10.1002\/14651858.CD002798.pub2-BIB47|cit47","first-page":"765","article-title":"Hepatic encephalopathy","volume-title":"Clinical Hepatology","volume":"1","author":"Blei","year":"1999"},{"issue":"6","key":"10.1002\/14651858.CD002798.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1471-4159.1982.tb07983.x","article-title":"The benzodiazepine\/GABA receptor complex: molecular size in brain synaptic membranes and in solution","volume":"39","author":"Chang","year":"1982","journal-title":"Journal of Neurochemistry"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD002798.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB50|cit50","volume-title":"The hepatic coma syndromes and lactulose","author":"Conn","year":"1979"},{"key":"10.1002\/14651858.CD002798.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7109","key":"10.1002\/14651858.CD002798.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test [see comments]","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002798.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB54|cit54","article-title":"Diagnosis and differential diagnosis of hepatic encephalopathy: implications for the design of clinical studies.","volume-title":"Advances in hepatic encephalopathy & metabolism in liver disease","author":"Ferenci","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB56|cit56","first-page":"605","article-title":"Hepatic encephalopathy","volume-title":"Hepatology. A textbook of liver disease","volume":"1","author":"Gitlin","year":"1996"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0168-8278(98)80301-2","article-title":"\"Negative trials\" are positive! [editorial]","volume":"28","author":"Gluud","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB58|cit58","first-page":"555","article-title":"Flumazenil vs placebo for hepatic encephalopathy (HE) in patients with cirrhosis: a meta-analysis [abstract]","volume":"28 Suppl","author":"Goulenok","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.2002.01191.x","article-title":"Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis","volume":"16","author":"Goulenok","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0013-4694(95)00200-6","article-title":"Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial","volume":"98","author":"Groeneweg","year":"1996","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD002798.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD002798.pub2-BIB62|cit62","first-page":"803","article-title":"Flumazenil: a benzodiazepine antagonist","volume":"12","author":"Hoffman","year":"1993","journal-title":"Clinical Pharmacy"},{"issue":"7211","key":"10.1002\/14651858.CD002798.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002798.pub2-BIB64|cit64","volume-title":"Code of Federal Regulations & International Conference on Harmonization Guidelines","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD002798.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/gut.46.4.546","article-title":"Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis","volume":"46","author":"Jalan","year":"2000","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD002798.pub2-BIB67|cit67","first-page":"301","article-title":"The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status","volume":"57","author":"Jones","year":"1984","journal-title":"The Yale Journal of Biology and Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002798.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1440-1746.1993.tb01529.x","article-title":"Hepatic encephalopathy","volume":"8","author":"Jones","year":"1993","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD002798.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between small and large randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9128","key":"10.1002\/14651858.CD002798.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? [see comments]","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"8583","key":"10.1002\/14651858.CD002798.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(88)91245-7","article-title":"Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?","volume":"1","author":"Mullen","year":"1988","journal-title":"Lancet"},{"issue":"8707","key":"10.1002\/14651858.CD002798.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0140-6736(90)91594-Z","article-title":"\"Endogenous\" benzodiazepine activity in body fluids of patients with hepatic encephalopathy","volume":"336","author":"Mullen","year":"1990","journal-title":"Lancet"},{"issue":"8262","key":"10.1002\/14651858.CD002798.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(82)92559-4","article-title":"Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system","volume":"1","author":"Schafer","year":"1982","journal-title":"Lancet"},{"issue":"6007","key":"10.1002\/14651858.CD002798.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/314168a0","article-title":"Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies","volume":"314","author":"Schoch","year":"1985","journal-title":"Nature"},{"issue":"5","key":"10.1002\/14651858.CD002798.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002798.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-6576.1995.tb04374.x","article-title":"Pharmacology of flumazenil","volume":"108","author":"Whitwam","year":"1995","journal-title":"Acta Anaesthesiologica Scandinavica Supplementum"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002798.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002798.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:12:36Z","timestamp":1628543556000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002798.pub2"}},"subtitle":[],"editor":[{"given":"Bodil","family":"Als-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,4,19]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002798.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD002798.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2004,4,19]]}}}